首页> 外文OA文献 >Omalizumab and Systemic mast cell activation diseases: a treatment opportunity for non-clonal disorder?

【2h】

Omalizumab and Systemic mast cell activation diseases: a treatment opportunity for non-clonal disorder?

机译：omalizumab和全身肥大细胞活化疾病：非克隆病症的治疗机会？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Marco Caminati; Elisa Olivieri; Roberta Zanotti; Patrizia Bonadonna;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Omalizumab treatment of systemic mast cell activation disease: experiences from four cases. [J] . Molderings GJ, Raithel M, Kratz F, Internal medicine. . 2011,第6期

机译：奥马珠单抗治疗系统性肥大细胞活化疾病：四例经验。
2. Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases [J] . Gerhard J. Molderings, Martin Raithel, Felix Kratz, Internal medicine. . 2011,第6期

机译：omalizumab治疗全身肥大细胞活化疾病：四种情况的经验
3. Successful use of omalizumab for prevention of anaphylaxis in a patient with non-clonal mast cell activation and postural tachycardia syndrome [J] . Chan S., Denman S., Savic S. Clinical and experimental allergy : . 2016,第12期

机译：奥马珠单抗成功用于预防非克隆性肥大细胞活化和体位性心动过速综合征的过敏反应
4. WHAT'S NEW IN THE TREATMENT OF LYMPHOMA AND MAST CELL DISEASE: PART 2 [C] . Kathi L. Smith Conference of the American Animal Hospital Association . 2016

机译：治疗淋巴瘤和肥大细胞病的新增功能：第2部分
5. Pathogenesis of coxsackievirus B3 induced myocarditis and systemic disease: Viral localization, direct injury and activation of host cell death machinery. [D] . Carthy, Christopher Michael. 2003

机译：柯萨奇病毒B3诱发的心肌炎和全身性疾病的发病机制：病毒定位，直接损伤和宿主细胞死亡机制的激活。
6. Successful treatment of idiopathic mast cell activation syndrome with low‐dose Omalizumab [O] . Renee Berry, Peter Hollingsworth, Michaela Lucas 2019

机译：小剂量奥马珠单抗成功治疗特发性肥大细胞活化综合征
7. Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases [O] . Gerhard J. Molderings, Martin Raithel, Felix Kratz, 2011

机译：omalizumab治疗全身肥大细胞活化疾病：四种情况的经验

Omalizumab and Systemic mast cell activation diseases: a treatment opportunity for non-clonal disorder?

著录项

引文网络

相似文献

相关主题

期刊订阅